Skip to content

Prediction of Clinical Efficacy of Acupuncture Treatment for Migraine Based on Machine Learning Algorithms: A DTI Study

Prediction of Clinical Efficacy of Acupuncture Treatment for Migraine Based on Machine Learning Algorithms: A DTI Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005202
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-08-26
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Acupuncture groups:Acupuncture treatment

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Comply with the diagnostic criteria of the International Classification of Headache Disorders III (ICHD-3 beta); 2)18-65 years old, right handedness; 3)A history of migraine for at least 1 year; 4)The frequency of migraine attack more than twice a month; 5)No acupuncture treatment or medication was used within 24 hours after the acute onset of migraine, and no preventive treatment for migraine during the past 3 months; 6)Sign written informed consent.

Exclusion criteria

Exclusion criteria: 1)Other types of primary headaches such as chronic migraine, tension-type headaches, nerve headache and cluster headache; 2)Any other secondary headaches or neurological diseases-headaches caused by intracranial diseases such as otolaryngological diseases, depression and Parkinson's disease; 3)Relatively severe life-threatening diseases, such as cardiovascular diseases, acute infectious diseases, hematological diseases, endocrine diseases, allergies or hemoptysis; 4)Use of prophylactic migraine medication and acupuncture treatment during the past three months. 5)Pregnancy, lactation and preparation for pregnancy; 6)Smoking, alcohol and drug abuse; 7)Patients with pain within 3 days before MR scan; 8)Any contraindications of acupuncture treatment, such as hematological diseases and local infections, etc; 9)Any contraindications for MRI exam, such as metal implants in the body, claustrophobia, etc.

Design outcomes

Primary

MeasureTime frame
Halving rate of headache days;

Secondary

MeasureTime frame
Migraine disability assessment;Beck depression inventory;Visual analogue scale;Self-rating anxiety scale;Headache impact test-6;

Contacts

Public ContactYa-nan Zhang
zhangyanan@bjzhongyi.com15901119002

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026